Showing results (21-30 of 398) with videos related to
Sort By:
Pageof 40
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2024
A patient journey audit tool (PJAT) to assess quality indicators in a nuclear medicine serviceKunthi Pathmaraj, Jessica Welch, Wesley Ng, et al.ANZ Journal of Surgery|July 26, 2016
Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markersLawrence F Lau, Carmel Murone, David S Williams, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment MethodsNarjess Ayati, Sze Ting Lee, S Rasoul Zakavi, et al.The Prostate|October 23, 2008
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapyMarcus P Kelly, Sze Ting Lee, F-T Lee, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 7, 2020
Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapseAntoine Leimgruber, Kevin Hickson, Sze Ting Lee, et al.Seminars in Nuclear Medicine|September 1, 2019
Novel Target Selection for Nuclear Medicine StudiesSze Ting Lee, I Burvenich, A M ScottOncotarget|October 31, 2015
Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathwaysDavid W Greening, Sze Ting Lee, Hong Ji, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2022
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian PerspectiveSze Ting Lee, Louise M Emmett, David A Pattison, et al.Clinical Lymphoma, Myeloma & Leukemia|August 9, 2025
Prognostic Utility of Quantitative PET Parameters on Baseline and Interim FDG-PET Scans in Hodgkin LymphomaNatalia Kovaleva, Shin Hnin Wai, Niamh Waters, et al.Clinical Lymphoma, Myeloma & Leukemia|January 27, 2023
Augmented ICE in Patients With Poor-Risk Refractory and Relapsed LymphomasSun Loo, Andrew Lim, Sze Ting Lee, et al.Pageof 40